A transdiagnostic approach of negative symptoms in psychiatric disorders: replication of a two-factor structure in major depressive disorder and bipolar disorder

被引:1
|
作者
Li, Shuai-Biao [1 ]
Zhang, Jian-Biao [2 ]
Liu, Chao [2 ]
Wang, Ling-Ling [3 ,4 ,5 ]
Hu, Hui-Xin [3 ,4 ,6 ]
Chu, Min-Yi [1 ]
Wang, Yi [3 ,4 ]
Lv, Qin-Yu [1 ,7 ]
Lui, Simon S. Y. [8 ]
Yi, Zheng-Hui [1 ,7 ,9 ]
Chan, Raymond C. K. [3 ,4 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, 600 South Wanping Rd, Shanghai, Peoples R China
[2] Nantong Fourth Peoples Hosp, Nantong, Jiangsu, Peoples R China
[3] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, CAS Key Lab Mental Hlth, 16 Lincui Rd, Beijing, Peoples R China
[4] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China
[5] Shanghai Normal Univ, Sch Psychol, Shanghai, Peoples R China
[6] Beijing Forestry Univ, Sch Humanities & Social Sci, Dept Psychol, Beijing, Peoples R China
[7] Fudan Univ, Huashan Hosp, Sch Med, Dept Psychiat, Shanghai, Peoples R China
[8] Univ Hong Kong, Sch Clin Med, Dept Psychiat, Hong Kong, Peoples R China
[9] Fudan Univ, Inst Mental Hlth, Shanghai, Peoples R China
关键词
Negative symptoms; Transdiagnostic; Latent structure; Major depressive disorder; Bipolar disorder; CLINICAL-ASSESSMENT INTERVIEW; OF-FIT INDEXES; SCHIZOPHRENIA; SCALE; INDIVIDUALS; DIMENSIONS; VALIDITY; APATHY;
D O I
10.1007/s00406-024-01934-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent empirical findings suggest that negative symptoms are not limited to schizophrenia (SCZ) but also present in major depressive disorder (MDD) and bipolar disorder (BD) patients. Although SCZ patients generally showed a latent structure comprising the motivation and pleasure (MAP) and expression (EXP) factors, it remains unclear whether the same latent structure exists in MDD and BD patients. We administered the Clinical Assessment Interview for Negative Symptoms (CAINS) and the Brief Negative Symptom Scale (BNSS) to 179 MDD patients and 152 BD patients. Confirmatory Factor Analysis (CFA) was conducted to examine the one-factor model, the two-factor model of the MAP and the EXP domain, the five-factor model of anhedonia, avolition, asociality, alogia, and blunted affect, and the hierarchical model comprising the first-order five-factor, and the second-order two-factor (MAP and EXP factors). We further examined the correlations between demographics and the negative symptom dimensions found in the best factor model. The CFA showed that, when the CAINS and the BNSS were combined together, the two-factor model of MAP and EXP provided the best model fit than other competing models, in the MDD alone sample, BD alone sample, and the combined clinical sample. The two-factor model of the MAP and EXP appears to be a stable, transdiagnostic latent structure of negative symptoms across BD and MDD. Clarifying negative symptoms in MDD and BD can facilitate future research on the underlying neural mechanisms of the MAP and EXP dimensions.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] A transdiagnostic approach to negative symptoms: exploring factor structure and negative symptoms in bipolar disorders
    Ihler, Henrik Myhre
    Lyngstad, Siv Hege
    Morch-Johnsen, Lynn Egeland
    Lagerberg, Trine Vik
    Melle, Ingrid
    Romm, Kristin Lie
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [2] INHIBITED TEMPERAMENT IS A TRANSDIAGNOSTIC FACTOR ACROSS SCHIZOPHRENIA, PSYCHOTIC BIPOLAR DISORDER, AND MAJOR DEPRESSIVE DISORDER
    Feola, Brandee
    Armstrong, Kristan
    Woodward, Neil
    Heckers, Stephan
    Blackford, Jennifer
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S278 - S279
  • [3] Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders
    David, Friederike S.
    Stein, Frederike
    Andlauer, Till F. M.
    Streit, Fabian
    Witt, Stephanie H.
    Herms, Stefan
    Hoffmann, Per
    Heilmann-Heimbach, Stefanie
    Opel, Nils
    Repple, Jonathan
    Jansen, Andreas
    Nenadic, Igor
    Papiol, Sergi
    Heilbronner, Urs
    Kalman, Janos L.
    Schaupp, Sabrina K.
    Senner, Fanny
    Schulte, Eva C.
    Falkai, Peter G.
    Schulze, Thomas G.
    Dannlowski, Udo
    Kircher, Tilo
    Rietschel, Marcella
    Noethen, Markus M.
    Krug, Axel
    Forstner, Andreas J.
    SCHIZOPHRENIA RESEARCH, 2023, 252 : 161 - 171
  • [4] Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder
    de Jong, Simone
    Abdalla Diniz, Mateus Jose
    Saloma, Andiara
    Gadelha, Ary
    Santoro, Marcos L.
    Ota, Vanessa K.
    Noto, Cristiano
    Curtis, Charlesg
    Newhouse, Stephen J.
    Patel, Hamel
    Hall, Lynsey S.
    O'Reilly, Paul F.
    Belangero, Sintia, I
    Bressan, Rodrigo A.
    Breen, Gerome
    Wray, Naomi R.
    Ripke, Stephan
    Mattheisen, Manuel
    Trzaskowski, Maciej
    Byrne, Enda M.
    Abdellaoui, Abdel
    Adams, Mark J.
    Agerbo, Esben
    Air, Tracy M.
    Andlauer, Till F. M.
    Bacanu, Silviu-Alin
    Baekvad-Hansen, Marie
    Beekman, Aartjan T. F.
    Bigdeli, Tim B.
    Binder, Elisabeth B.
    Blackwood, Douglas H. R.
    Bryois, Julien
    Buttenschon, Henriette N.
    Bybjerg-Grauholm, Jonas
    Cai, Na
    Castelao, Enrique
    Christensen, Jane Hvarregaard
    Clarke, Toni-Kim
    Coleman, Jonathan R., I
    Colodro-Conde, Lucia
    Couvy-Duchesne, Baptiste
    Craddock, Nick
    Crawford, Gregory E.
    Davies, Gail
    Deary, Ian J.
    Degenhardt, Franziska
    Derks, Eske M.
    Direk, Nese
    Dolan, Conor, V
    Dunn, Erin C.
    COMMUNICATIONS BIOLOGY, 2018, 1
  • [5] Classification for psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder using machine learning
    Yang, Qingxia
    Xing, Qiaowen
    Yang, Qingfang
    Gong, Yaguo
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 5054 - 5064
  • [6] Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder
    Simone de Jong
    Mateus Jose Abdalla Diniz
    Andiara Saloma
    Ary Gadelha
    Marcos L. Santoro
    Vanessa K. Ota
    Cristiano Noto
    Charles Curtis
    Stephen J. Newhouse
    Hamel Patel
    Lynsey S. Hall
    Paul F. O`Reilly
    Sintia I. Belangero
    Rodrigo A. Bressan
    Gerome Breen
    Communications Biology, 1
  • [7] Hypofrontality and negative symptoms in major depressive disorder
    Galynker, II
    Cai, J
    Ongseng, F
    Finestone, H
    Dutta, E
    Serseni, D
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (04) : 608 - 612
  • [8] Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
    Shin, Dongyoon
    Rhee, Sang Jin
    Shin, Daun
    Joo, Eun-Jeong
    Jung, Hee Yeon
    Roh, Sungwon
    Lee, Sang-Hyuk
    Kim, Hyeyoung
    Bang, Minji
    Lee, Kyu Young
    Kim, Se Hyun
    Lee, Jihyeon
    Kim, Yoseop
    Yeo, Injoon
    Kim, Yeongshin
    Kim, Jaenyeon
    Kwon, Jun Soo
    Ha, Kyooseob
    Ahn, Yong Min
    Kim, Youngsoo
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (06):
  • [9] Effort-cost computation in a transdiagnostic psychiatric sample: Differences among patients with schizophrenia, bipolar disorder, and major depressive disorder
    Zou, Ying-Min
    Ni, Ke
    Wang, Yan-Yu
    Yu, En-Qing
    Lui, Simon S. Y.
    Zhou, Fu-Chun
    Yang, Han-Xue
    Cohen, Alex S.
    Strauss, Gregory P.
    Cheung, Eric F. C.
    Chan, Raymond C. K.
    PSYCH JOURNAL, 2020, 9 (02) : 210 - 222
  • [10] Screening for Borderline Personality Disorder in Psychiatric Outpatients With Major Depressive Disorder and Bipolar Disorder
    Zimmerman, Mark
    Balling, Caroline
    Dalrymple, Kristy
    Chelminski, Iwona
    JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (01)